BR Biopharma (NASDAQ:BRBI) Releases Earnings Results

BR Biopharma (NASDAQ:BRBI) issued its quarterly earnings data on Tuesday. The company reported $0.05 earnings per share for the quarter, FiscalAI reports. The firm had revenue of $23.80 million during the quarter.

BR Biopharma Stock Up 0.8%

NASDAQ BRBI traded up $0.06 during trading on Thursday, hitting $7.24. The company’s stock had a trading volume of 200 shares, compared to its average volume of 3,672. BR Biopharma has a 52 week low of $6.87 and a 52 week high of $16.61. The firm has a market cap of $85.50 million, a P/E ratio of 90.50 and a beta of 0.43. The firm has a 50 day moving average price of $11.61 and a 200 day moving average price of $12.63.

BR Biopharma Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 4th. Shareholders of record on Monday, August 17th were given a $0.1415 dividend. The ex-dividend date of this dividend was Monday, August 17th. This represents a $0.57 annualized dividend and a yield of 7.8%. This is a decrease from BR Biopharma’s previous quarterly dividend of $0.1470. BR Biopharma’s dividend payout ratio (DPR) is presently 525.00%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Citigroup downgraded shares of BR Biopharma from a “buy” rating to a “hold” rating in a report on Tuesday, October 27th. Weiss Ratings upgraded shares of BR Biopharma from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, October 2nd. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Reduce”.

About BR Biopharma

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.